We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gene Expression in White Cells Indicates Lung Cancer

By Labmedica staff writers
Posted on 28 May 2008
Print article
Examining gene expression in a person's own circulating white blood cells can give an indication of whether or not the person has lung cancer. The simple blood test could accurately detect lung cancer in its earliest stages.

The possibility of developing a noninvasive test to distinguish cancerous from benign lesions in the lungs has enormous implications, not just for the world of medicine, but also for every patient who has gone through the distressing experience of having to wait for conclusive biopsy results after preliminary testing.

Because lung cancer is a very diverse disease, screening for it can be very difficult, Dr. Anil Vachani assistant professor of medicine at the University of Pennsylvania Medical School (Philadelphia, PA, USA) said, " CT [computed tomography] screening results in the detection of lung nodules in 20 to 60% of subjects. This high false-positive rate requires patients to undergo extensive follow-up investigations.” He and his colleagues decided to look at the gene expression in the patient's circulating blood cells rather screening for factors released by the incipient tumor into the blood stream. "We found that the types of genes present in these cells could tell us whether or not cancer was present,” explained Dr. Vachani.

To test the accuracy and validity of the method, the team recruited 44 patients with early stage lung cancer and 52 control subjects who were matched for age, smoking status, gender, and race. They then used a number of genetic arrays to determine the best targets for detecting the presence of cancer. They found that a 15-gene array had the highest accuracy, at 87%.

"These findings suggest that lung cancers interact with circulating white blood cells and change the types of genes that are active in these cells. This finding can be potentially used to develop a noninvasive diagnostic test for patients suspected of having lung cancer,” said Dr. Vachani.

This study was presented at the American Thoracic Society's 2008 International Conference in Toronto (ON, Canada) on May 20, 2008.


Related Links:
University of Pennsylvania Medical School
New
Gold Member
Troponin T QC
Troponin T Quality Control
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
EBV DNA Quantitative Fluorescence Diagnostic Kit
S3015E EBV
New
Clinical Sample Concentrator
QIAamp DSP Virus Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.